Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001140361-24-009789
Filing Date
2024-02-27
Accepted
2024-02-27 17:05:49
Documents
12
Effectiveness Date
2024-02-27

Document Format Files

Seq Description Document Type Size
1 S-3ASR ny20022273x1_s3asr.htm S-3ASR 326991
2 EXHIBIT 4.8 ny20022273x1_ex4-8.htm EX-4.8 507569
3 EXHIBIT 5.1 ny20022273x1_ex5-1.htm EX-5.1 51342
4 EXHIBIT 23.1 ny20022273x1_ex23-1.htm EX-23.1 4321
5 EXHIBIT 25.1 ny20022273x1_ex25-1.htm EX-25.1 153068
6 FILING FEES TABLE ny20022273x1_ex107.htm EX-FILING FEES 42470
7 logo_biocryst2a.jpg GRAPHIC 48001
8 ny20022273x1ex5-1_image01.jpg GRAPHIC 5464
9 ny20022273x1ex99-1_image01.jpg GRAPHIC 18090
10 ny20022273x1ex99-1_image02.jpg GRAPHIC 8506
11 ny20022273x1ex99-1_image03.jpg GRAPHIC 5311
12 ny20022273x1ex99-1_image04.jpg GRAPHIC 24629
  Complete submission text file 0001140361-24-009789.txt   1238536
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277417 | Film No.: 24688219
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)